4 European Projects Found
Searched on 125080 European Projects
FINISHED
AutoTuning and Adaptivity appRoach for Energy efficient eXascale HPC systems (ANTAREX)
Start date: Sep 1, 2015, End date: Aug 31, 2018,
Energy-efficient heterogeneous supercomputing architectures need to be coupled with a radically new software stack capable of exploiting the benefits offered by the heterogeneity at all the different levels (supercomputer, job, node) to meet the scalability and energy efficiency required by Exascale supercomputers.ANTAREX will solve these challenging problems by proposing a disruptive holistic app ...
Read Project
9
Partners Participants
FINISHED
GAbapentin in Paediatric Pain (GAPP)
Start date: Jul 1, 2013, End date: Jun 30, 2017,
Chronic pain is estimated to affect 15-20% of children with varying disabilities. Due to the paucity of clinical information and appropriate medicinal products, in clinical practice paediatric patients are often under-treated causing profound impact on their QoL.To date, opioids, non-steroid anti-inflammatory drugs (NSAIDs), antidepressants and anticonvulsants are used to treat pain, but only few ...
Read Project
16
Partners Participants
FINISHED
TargetIng novel MEchanisms of Resolution in inflammation (TIMER)
Start date: Jan 1, 2012, End date: Dec 31, 2015,
Resolution of inflammation is a key determinant of pathology, and an active process which involves diverse pathways and molecules. The general objective of the TIMER Consortium is to identify and validate new molecules involved in the resolution of inflammation as a basis for the development of innovative therapeutic strategies in chronic inflammatory and autoimmune diseases. The project will invo ...
Read Project
13
Partners Participants
FINISHED
MAGNETIC NANOCONTAINERS FOR COMBINED HYPERTHERMIA AND CONTROLLED DRUG RELEASE (MAGNIFYCO)
Start date: Sep 1, 2009, End date: Feb 28, 2013,
The aim of this project is the assembly and the fabrication of a new generation of multifunctional nanostructures for performing combined hyperthermia and controlled drug release, specifically targeted to cancer cells. The “magnetic nanocontainers” we intend to develop can perform at the same time cell recognition, hyperthermia treatment, and, as a consequence of the heat and /or cell environment ...
Read Project
